FDA approves Edarbi to treat high blood pressure (source: FDA Press Announcement) On Friday, February 25, 2011, The U.S. Food and Drug Administration approved Edarbi tablets (azilsartan medoxomil) to treat high blood pressure (hypertension) in adults. Data from clinical studies showed Edarbi to be more effective in lowering 24-hour blood pressure compared with two other […]
Continue ReadingFDA Approval: Ofirmev
PRNewswire via COMTEX News Network/ — Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced last week that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OFIRMEV(TM) (acetaminophen) injection, the first and only intravenous (IV) formulation of acetaminophen to be approved in the United States. OFIRMEV is indicated for the management of mild to […]
Continue ReadingBrand Refreshment: Belk vs. Gap
…………………………………………………………………………………………………………………………………………………. Much of October’s design buzz was focused on the new Gap logo. With the change came die-hard Gap customers commenting on blogs, Facebook sites, and within the design community. Marka Hansen, president of Gap North America, initially defended the logo, writing that the move brings Gap into the modern age. “We want our customers […]
Continue ReadingWelcome back Elizabeth!
…………………………………………………………………………………………………………………………………. Just in case you’ve been under a rock for the past few months, on April 6th Zoey Elizabeth McGaha arrived a healthy 17.5 inches long and 6 lbs 9 oz. Congratulations Elizabeth! We are so happy for you and look forward to hearing all of your baby-mama stories. Plus I’m sure you’ll have plenty […]
Continue Reading